Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S. Read more
Novavax Announces Expanded Approval of Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan Read more
European Commission Approves RINVOQ (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis Read more
Ionis announces that FDA accepts New Drug Application and grants Priority Review of tofersen for a rare, genetic form of ALS Read more
Enhertu granted Priority Review in the US for patients with HER2-low metastatic breast cancer Read more
Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox Read more
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA Read more
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases Read more
European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation Read more